Brief: Medipost receives patent

Medipost Co

30/11/2016 02:35

Nov 30 (Reuters) - Medipost Co Ltd  078160.KQ  : 
 
    * Says it received China patent on Nov. 29, for composition 
for the diagnosis, prevention or treatment of disease related to 
cells expressing IL-8 or GRO-alpha, comprising UCB-MSCs 
    * Says Patent application number is 200880104400.X 
     
     
    Source text in Korean: https://goo.gl/jRVZ5R 
    Further company coverage:  078160.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))